Showing results (1-10 of 29) with videos related to
Sort By:
Pageof 3
Antibody Therapeutics|September 25, 2025
Structure and function of therapeutic antibodies approved by the US FDA in 2024William R StrohlBiodrugs : Clinical Immunotherapeutics, Biopharmaceuticals and Gene Therapy|July 17, 2015
Fusion Proteins for Half-Life Extension of Biologics as a Strategy to Make BiobettersWilliam R StrohlCurrent Drug Discovery Technologies|October 31, 2013
Antibody discovery: sourcing of monoclonal antibody variable domainsWilliam R StrohlAntibody Therapeutics|April 15, 2024
Structure and function of therapeutic antibodies approved by the US FDA in 2023William R StrohlCurrent Opinion in Biotechnology|November 10, 2009
Optimization of Fc-mediated effector functions of monoclonal antibodiesWilliam R StrohlAntibodies (Basel, Switzerland)|September 24, 2019
Bispecific T-Cell Redirection versus Chimeric Antigen Receptor (CAR)-T Cells as Approaches to Kill Cancer CellsWilliam R Strohl, Michael NasoApplied and Environmental Microbiology|March 7, 2003
Characterization of the Streptomyces sp. strain C5 snp locus and development of snp-derived expression vectorsCharles L DeSanti, William R StrohlExpert Opinion on Biological Therapy|July 27, 2013
Potential therapeutic roles for antibody mixturesT Shantha Raju, William R StrohlBiodrugs : Clinical Immunotherapeutics, Biopharmaceuticals and Gene Therapy|July 3, 2017
Adeno-Associated Virus (AAV) as a Vector for Gene TherapyMichael F Naso, Brian Tomkowicz, William L Perry, et al.Pageof 3